Panacea Venture Healthcare Fund II, L.P. 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-01 8:30 pm Purchase | 2024-10-25 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Panacea Venture Healthcare Fund II, L.P. | 5,500,000 9.980% | 5,500,000 (New Position) | Filing |